Stockscreener 앱 받기
37.29
3.18%
1.15
시장 영업 전:
36.64
-0.65
-1.74%
전일 마감가:
$36.14
열려 있는:
$38.21
하루 거래량:
2.30M
Relative Volume:
2.81
시가총액:
$4.04B
수익:
$355.75M
순이익/손실:
$-270.85M
주가수익비율:
-13.81
EPS:
-2.7
순현금흐름:
$-218.63M
1주 성능:
+5.34%
1개월 성능:
+7.65%
6개월 성능:
+50.00%
1년 성능:
+123.03%
1일 변동 폭
$36.94
$38.70
1주일 범위
$33.33
$39.77
52주 변동 폭
$13.48
$39.77
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
4560 JINKE ROAD, SHANGHAI
ZLAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
37.29 | 4.04B | 355.75M | -270.85M | -218.63M | -2.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month High – What’s Next? - Defense World
Altice USA Inc [ATUS] Shares Jump Approximately 12.30% Over the Year - Knox Daily
Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - BioSpace
US Bancorp DE Has $154,000 Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Insider Monkey
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Reaches New 12-Month High – Still a Buy? - Defense World
Brokers Set Expectations for Zai Lab FY2025 Earnings - Defense World
Insider Sell: Richard Gaynor Sells 2,500 Shares of Zai Lab Ltd (ZLAB) - GuruFocus.com
Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet - MSN
Leerink Partnrs Forecasts Zai Lab FY2026 Earnings - Defense World
Zai Lab (NASDAQ:ZLAB) Receives “Neutral” Rating from Bank of America - Defense World
B of A Securities Downgrades Zai Lab LimitedDepositary Receipt () (ZLAB) - MSN
Zai Lab Announces Participation in Investor Conferences in March 2025 - Business Wire
Zai Lab Limited (NASDAQ:ZLAB) Q4 2024 Earnings Call Transcript - Insider Monkey
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Yahoo Finance
Equities Analysts Set Expectations for Zai Lab Q1 Earnings - Armenian Reporter
Here's Why 'Trend' Investors Would Love Betting on Zai Lab Limited (ZLAB) - MSN
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Zai Lab Limited (ZLAB) Surges 9.0%: Is This an Indication of Further Gains? - Nasdaq
Q1 Earnings Forecast for Zai Lab Issued By Leerink Partnrs - Defense World
Financial Snapshot: Analyzing Zai Lab Limited ADR (ZLAB)’s Key Ratio Metrics - The Dwinnex
Principal Financial Group Inc. Invests $46.17 Million in Zai Lab Limited (NASDAQ:ZLAB) - Armenian Reporter
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday - Benzinga
With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business - Yahoo Finance
Zai Lab Limited (NASDAQ:ZLAB) Short Interest Up 27.4% in January - Defense World
Sidley Advised Zai Lab on its Offering of ADSs and Issuance of Underlying Shares - Legal Desire News Network
Analysts Set Expectations for Zai Lab FY2024 Earnings - Defense World
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Cantor Fitzgerald - Defense World
Forge Global Holdings Inc (FRGE)’s stock chart: A technical perspective - US Post News
Perimeter Solutions Inc (PRM)’s stock price in review: A technical analysis - US Post News
Was anything positive for Zai Lab Limited ADR (ZLAB) stock last session? - US Post News
United Natural Foods Inc (UNFI)’s stock performance: a year in review - US Post News
A stock that deserves closer examination: Cybin Inc (CYBN) - US Post News
Market Highlights: Zai Lab Limited ADR (ZLAB) Ends on a Low Note at 26.77 - The Dwinnex
Daily Progress: Concentrix Corp (CNXC) Drop -0.89, Closing at 48.99 - The Dwinnex
Market Watch: Rekor Systems Inc (REKR)’s Noteworthy Gain, Closing at 2.20 - The Dwinnex
Closing Strong: Selective Insurance Group Inc (SIGI) Ends at 83.49, Up 0.87 from Last Close - The Dwinnex
ZLAB (Zai Lab Limited ADR) may reap gains as insiders became active recently - Knox Daily
Zai Lab Limited ADR (ZLAB) looking to reclaim success with recent performance - SETE News
19,502 Shares in Zai Lab Limited (NASDAQ:ZLAB) Purchased by SG Americas Securities LLC - MarketBeat
SG Americas Securities LLC Makes New $511,000 Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Wall Street Analysts Believe Zai Lab Limited (ZLAB) Could Rally 95.6%: Here's is How to Trade - Yahoo Finance
Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire
FDA gives Zai Lab’s small cell lung cancer therapeutic orphan drug designation - Mugglehead
Cantor Fitzgerald Comments on Zai Lab FY2025 Earnings - Defense World
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) - Yahoo Finance
Here’s Why Analysts Are Bullish on Zai Lab Limited (ZLAB) - Insider Monkey
Zai Lab Limited (NASDAQ:ZLAB) Position Decreased by JPMorgan Chase & Co. - Defense World
Schrodinger Inc (NASDAQ: SDGR) Up 1.66%: This Is What Analysts Are Now Forecasting - Stocks Register
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.89%
0.13%
자본화:
|
볼륨(24시간):